XML 20 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transactions - Textual (Details) (USD $)
1 Months Ended 0 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 9 Months Ended 1 Months Ended 1 Months Ended 0 Months Ended 1 Months Ended 1 Months Ended
Feb. 29, 2012
Chromadex Corporation [Member]
Feb. 29, 2012
Biozone Pharmaceuticals Inc [Member]
Nov. 30, 2010
Fabrus Inc [Member]
Sep. 21, 2009
Cocrystal [Member]
Sep. 30, 2009
Cocrystal [Member]
Sep. 30, 2009
Convertible Preferred Stock [Member]
Jan. 30, 2013
Notes [Member]
Notes Due February 1, 2033 [Member]
Sep. 21, 2011
Dr Frost [Member]
Aug. 31, 2011
Dr Frost [Member]
Sep. 21, 2011
Dr Frost [Member]
Biozone Pharmaceuticals Inc [Member]
Aug. 29, 2013
Dr Frost [Member]
PROLOR [Member]
Sep. 30, 2013
Dr Frost [Member]
Reimbursement Of Travel Expense [Member]
Sep. 30, 2012
Dr Frost [Member]
Reimbursement Of Travel Expense [Member]
Sep. 30, 2013
Dr Frost [Member]
Reimbursement Of Travel Expense [Member]
Sep. 30, 2012
Dr Frost [Member]
Reimbursement Of Travel Expense [Member]
Sep. 21, 2011
Dr. Hsiao [Member]
Aug. 31, 2011
Dr. Hsiao [Member]
Sep. 21, 2011
Dr. Hsiao [Member]
Biozone Pharmaceuticals Inc [Member]
Aug. 29, 2013
Dr. Hsiao [Member]
PROLOR [Member]
Aug. 31, 2011
Mr. Rubin [Member]
Sep. 21, 2011
Mr. Rubin [Member]
Biozone Pharmaceuticals Inc [Member]
Aug. 29, 2013
Mr. Rubin [Member]
PROLOR [Member]
Jan. 30, 2013
Frost Gamma Investments Trust and Hsu Gamma Investment, L.P. [Member]
Notes [Member]
Notes Due February 1, 2033 [Member]
Dec. 31, 2012
Avi Properties LLC [Member]
sqft
Sep. 30, 2013
Teva [Member]
FineTech [Member]
Feb. 29, 2012
Scripps Research Institute [Member]
Feb. 29, 2012
Gamma Trust [Member]
Chromadex Corporation [Member]
Sep. 30, 2012
Gamma Trust [Member]
Biozone Pharmaceuticals Inc [Member]
Apr. 30, 2012
Gamma Trust [Member]
Biozone Pharmaceuticals Inc [Member]
Feb. 29, 2012
Hsu Gamma [Member]
Chromadex Corporation [Member]
Nov. 30, 2010
Dr. Lerner [Member]
Fabrus Inc [Member]
Jun. 30, 2009
Dr. Lerner [Member]
Sorrento [Member]
Sep. 21, 2011
Aero Pharmaceuticals Inc [Member]
Biozone Pharmaceuticals Inc [Member]
May 16, 2011
Aero Pharmaceuticals Inc [Member]
Biozone Pharmaceuticals Inc [Member]
Sep. 21, 2011
Mr. Prego Novo [Member]
Sep. 21, 2011
Mr. Prego Novo [Member]
Biozone Pharmaceuticals Inc [Member]
Nov. 30, 2010
Gamma Trust and Hsu Gamma [Member]
Fabrus Inc [Member]
Jun. 30, 2010
Academia Sinica [Member]
Sep. 30, 2009
Frost Group, LLC [Member]
Installment
Aug. 31, 2012
Real Estate Holdings LLC [Member]
Nov. 30, 2007
Real Estate Holdings LLC [Member]
sqft
Related Party Transaction [Line Items]                                                                                  
Beneficially owned held by members     13.00%         46.00% 36.00% 9.20% 5.00%         12.00% 6.00% 1.70% 5.00% 1.00% 1.00% 5.00%         16.00%     1.00%         23.00% 8.20%          
Debt face amount             $ 175,000,000.0                               $ 175,000,000                                    
Period of lease                                               5 years                                  
Square feet of laboratory                                               44,000                                 8,300
Payments of lease per month                                               18,000                                 18,000
Exceeds consumer price index                                               5.00%                                  
Sale of API to TEVA                                                 100,000                                
Fund for research agreement                                                   900,000                              
Research agreement maturity period                                                   5 years                              
Approximate funding for development of technology                                                   200,000                              
Period for development of technology                                                   3 years                              
Beneficially owned held by owners 1.50%                                                                                
Invested in common shares 1,000,000 1,700,000                                                                              
Convertible senior notes interest rate   10.00%                                                                              
Par value   $ 0.20                                                                              
Warrants duration   10 years                                                                              
Warrants to purchase common shares   8,500,000                                                                              
Exercise price per share   $ 0.40                                                                              
Issue of common stock / Issue of common stock against acquisition                                                                 13,914 8,331,396              
Loan to bzne                                                       100,000 300,000                        
Investment was part of financing for Fabrus                                                                         2,100,000        
Ownership percentage held by director                                                             5.00%                    
Research and development agreement amount                                                                           200,000      
Invested in common shares       2,500,000 2,500,000                                                     2,300,000                  
Equity method investment, number of shares purchased           1,701,723                                                                      
Previous investment by a group of investor                                                                             5,000,000    
Additional investment by a group of investor                                                                             5,000,000    
Number of equal installments payable for additional investment                                                                             2    
Lease rent per month for fifth year                                                                                 24,000
Credit for tenant improvements                                                                                 30,000
Period of lease agreement                                                                               6 months  
Reimbursement paid to related party for travel                       $ 19,000 $ 52,000 $ 37,000 $ 181,000